HRP20120147T1 - Titracija tapentadola - Google Patents

Titracija tapentadola Download PDF

Info

Publication number
HRP20120147T1
HRP20120147T1 HR20120147T HRP20120147T HRP20120147T1 HR P20120147 T1 HRP20120147 T1 HR P20120147T1 HR 20120147 T HR20120147 T HR 20120147T HR P20120147 T HRP20120147 T HR P20120147T HR P20120147 T1 HRP20120147 T1 HR P20120147T1
Authority
HR
Croatia
Prior art keywords
dose
tapentadol
administration
administration interval
interval
Prior art date
Application number
HR20120147T
Other languages
English (en)
Croatian (hr)
Inventor
Lange Claudia
Rombout Ferdinand
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120147(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20120147T1 publication Critical patent/HRP20120147T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesive Tapes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20120147T 2007-04-23 2008-04-21 Titracija tapentadola HRP20120147T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
HRP20120147T1 true HRP20120147T1 (hr) 2012-03-31

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120147T HRP20120147T1 (hr) 2007-04-23 2008-04-21 Titracija tapentadola

Country Status (21)

Country Link
US (4) US20090012180A1 (enExample)
EP (5) EP1985292A1 (enExample)
JP (4) JP5933176B2 (enExample)
KR (3) KR20100017267A (enExample)
CN (1) CN101730530B (enExample)
AT (1) ATE534378T1 (enExample)
AU (1) AU2008241013B2 (enExample)
CA (1) CA2683786C (enExample)
CY (1) CY1112320T1 (enExample)
DK (1) DK2148670T3 (enExample)
ES (1) ES2378255T3 (enExample)
HR (1) HRP20120147T1 (enExample)
IL (1) IL201479A (enExample)
MX (1) MX2009011444A (enExample)
NZ (1) NZ580415A (enExample)
PL (1) PL2148670T3 (enExample)
PT (1) PT2148670E (enExample)
RU (1) RU2472497C2 (enExample)
SI (1) SI2148670T1 (enExample)
WO (1) WO2008128740A1 (enExample)
ZA (1) ZA200907355B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
JP6216489B2 (ja) * 2008-10-30 2017-10-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 新規の、効力のあるタペンタドール剤形
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US20130116333A1 (en) * 2010-05-05 2013-05-09 Ratiopharm Gmbh Solid tapentadol in non-crystalline form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
HRP20161166T1 (hr) * 2010-06-30 2016-11-04 Grünenthal GmbH Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
EP3650439B1 (en) * 2010-07-23 2021-02-24 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
RS54711B1 (sr) * 2011-03-04 2016-08-31 Grünenthal GmbH Parenteralno davanje tapentadola
SI3287123T1 (sl) 2011-03-04 2020-07-31 Gruenenthal Gmbh Vodna farmacevtska formulacija tapentadola za peroralno uporabo
KR101911362B1 (ko) 2011-03-04 2018-10-25 그뤼넨탈 게엠베하 타펜타돌을 함유하는 반고체 수성 약제학적 조성물
PL2694050T3 (pl) * 2011-04-05 2020-03-31 Grünenthal GmbH Tapentadol do stosowania w leczeniu bólu związanego z nerwobólami nerwu trójdzielnego
US20120309841A1 (en) * 2011-04-05 2012-12-06 Gruenenthal Gmbh Method of Inhibiting Chronification of Pain
RS60152B1 (sr) 2011-04-29 2020-05-29 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
WO2014152296A1 (en) * 2013-03-15 2014-09-25 Mallinckrodt Llc Abuse deterrent solid dosage form for immediate release with functional score
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
PT3479823T (pt) 2015-03-27 2020-09-29 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
JP6853791B2 (ja) * 2015-05-26 2021-03-31 テクノファージ， インベスティガサン エ デセンボルビメント エム ビオテクノロジア，エスエー パーキンソン病及び関連する障害の治療における使用のための組成物
WO2017148595A1 (en) * 2016-02-29 2017-09-08 Grünenthal GmbH Titration of cebranopadol
EP3515412B1 (en) 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
AU2021237693A1 (en) 2020-03-16 2022-09-08 Grünenthal GmbH Scored tablet
WO2022194941A1 (en) * 2021-03-17 2022-09-22 Actelion Pharmaceuticals Ltd Pharmaceutical dosage system
US20240238221A1 (en) * 2021-05-07 2024-07-18 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
MXPA05006334A (es) * 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol

Also Published As

Publication number Publication date
PT2148670E (pt) 2012-01-24
US20170079938A1 (en) 2017-03-23
CA2683786C (en) 2021-10-26
IL201479A0 (en) 2010-05-31
IL201479A (en) 2016-04-21
ZA200907355B (en) 2010-08-25
EP1985292A1 (en) 2008-10-29
US20160074342A1 (en) 2016-03-17
JP2018030864A (ja) 2018-03-01
KR102078999B1 (ko) 2020-02-19
WO2008128740A1 (en) 2008-10-30
ES2378255T3 (es) 2012-04-10
KR20100017267A (ko) 2010-02-16
EP2148670A1 (en) 2010-02-03
CN101730530A (zh) 2010-06-09
ATE534378T1 (de) 2011-12-15
CA2683786A1 (en) 2008-10-30
EP2422778A1 (en) 2012-02-29
US11344512B2 (en) 2022-05-31
US20190290603A1 (en) 2019-09-26
RU2009142940A (ru) 2011-05-27
KR20180004839A (ko) 2018-01-12
WO2008128740A8 (en) 2010-06-17
NZ580415A (en) 2012-04-27
JP5933176B2 (ja) 2016-06-08
PL2148670T3 (pl) 2012-04-30
EP2148670B1 (en) 2011-11-23
AU2008241013A1 (en) 2008-10-30
EP3603630A1 (en) 2020-02-05
US20090012180A1 (en) 2009-01-08
MX2009011444A (es) 2009-11-05
CN101730530B (zh) 2013-10-23
EP3143993A1 (en) 2017-03-22
SI2148670T1 (sl) 2012-03-30
JP2019131598A (ja) 2019-08-08
HK1140940A1 (en) 2010-10-29
AU2008241013B2 (en) 2013-06-20
DK2148670T3 (da) 2012-03-12
KR20150027840A (ko) 2015-03-12
CY1112320T1 (el) 2015-12-09
JP2010531296A (ja) 2010-09-24
RU2472497C2 (ru) 2013-01-20
JP2016128468A (ja) 2016-07-14

Similar Documents

Publication Publication Date Title
HRP20120147T1 (hr) Titracija tapentadola
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
JP2009102342A5 (enExample)
MX2008010155A (es) Composiciones virucidales que contienen metal y sus usos.
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
JP2012533554A5 (enExample)
SI2501234T1 (en) Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
RU2007103306A (ru) Композиции на основе ризедроната и способы их применения
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
RU2487707C2 (ru) Применение парацетамола и ибупрофена в лечении
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
HRP20130071T1 (hr) Poboljšani testosteron u gelu i naäśin primjene
HRP20090679T1 (hr) Upotreba oksikodona za liječenje organske boli
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
HRP20120228T1 (hr) Kladribinski režim za liječenje multiple skleroze
JP2019529559A5 (enExample)
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
MX2024008330A (es) Combinacion de obicetrapib e inhibidor de sglt2
Chhina et al. Local Drug Delivery.
US20080045482A1 (en) Compositions and methods for the treatment of viral infections
MA27157A1 (fr) Methode de traitement d'affections osseuses.
AR066667A1 (es) Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa